Literature DB >> 16928526

Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer.

Robert J Korst1, Amanda L Kansler, Jeffrey L Port, Paul C Lee, Nasser K Altorki.   

Abstract

BACKGROUND: To determine the eventual outcome of abnormalities detected on surveillance computed tomography (CT) in patients with previously resected nonsmall-cell lung cancer (NSCLC), and to assess the accuracy of CT when used by the thoracic surgeon, and to determine the characteristics of abnormalities on CT that correlate with the development of recurrent NSCLC.
METHODS: A cohort of patients who had abnormal postoperative CT scans of the chest and upper abdomen in 2002 were followed up into 2005. Abnormalities consisted of pulmonary nodules, pleural effusions, or adenopathy. Data collected included recurrence patterns, the availability of previous scans for comparison, the interval between initial resection and the abnormal CT, nodule size, growth, and multiplicity, as well as progression of pleural effusions or adenopathy.
RESULTS: In all, 105 scans in 92 patients were read as abnormal in 2002 by the radiologist. After further investigation or follow-up, or both, for a mean of 3.2 years, 78% of patients who had recurrent NSCLC had their site of first recurrence inside the chest. The negative predictive value of CT when used by the thoracic surgeon was 99%; however, the positive predictive value was only 53%. Abnormalities that correlated with the diagnosis of recurrent cancer included pulmonary nodules that either grew or were larger than 1 cm and pleural effusions that developed after the first postoperative year.
CONCLUSIONS: Intrathoracic recurrent NSCLC was rarely missed by the surgeon utilizing surveillance CT, but a significant number of negative investigations were generated by its use. Characteristics of abnormal surveillance CT findings exist that correlate with the presence of malignancy.

Entities:  

Mesh:

Year:  2006        PMID: 16928526     DOI: 10.1016/j.athoracsur.2006.03.062

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer.

Authors:  Waël C Hanna
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Characteristics and timing of recurrence during postoperative surveillance after curative resection for lung adenocarcinoma.

Authors:  Terumoto Koike; Tatsuya Goto; Akihiko Kitahara; Seijiro Sato; Masayuki Saitoh; Takehisa Hashimoto; Osamu Namura; Masashi Takahashi; Shin-Ichi Toyabe; Masanori Tsuchida
Journal:  Surg Today       Date:  2017-05-04       Impact factor: 2.549

3.  Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancer.

Authors:  Hari B Keshava; Kay See Tan; Joe Dycoco; James Huang; Alison Berkowitz; Dyana Sumner; Amy Devigne; Prasad Adusumilli; Manjit Bains; Matthew Bott; James Isbell; Robert Downey; Daniela Molena; Bernard Park; Gaetano Rocco; Smita Sihag; David R Jones; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2021-11-20       Impact factor: 6.439

4.  Routine follow-up after surgical treatment of lung cancer: is chest CT useful?

Authors:  Juliana B F Morellato; Marcos D Guimarães; Maria L L Medeiros; Hélio A Carneiro; Alex D Oliveira; João P O Medici; Marcus V B Baranauskas; Jefferson L Gross
Journal:  J Bras Pneumol       Date:  2021-08-11       Impact factor: 2.624

5.  Does the method of radiologic surveillance affect survival after resection of stage I non-small cell lung cancer?

Authors:  Traves D Crabtree; Varun Puri; Simon B Chen; David S Gierada; Jennifer M Bell; Stephen Broderick; A Sasha Krupnick; Daniel Kreisel; G Alexander Patterson; Bryan F Meyers
Journal:  J Thorac Cardiovasc Surg       Date:  2014-08-08       Impact factor: 5.209

Review 6.  Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival?

Authors:  Dharshika Srikantharajah; Abeer Ghuman; Myura Nagendran; Mahiben Maruthappu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08-01

7.  Stage II-IV lung cancer cases with lymphovascular invasion relapse within 2 years after surgery.

Authors:  Satoshi Shiono; Naoki Kanauchi; Naoki Yanagawa; Masami Abiko; Toru Sato
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-11-02

8.  Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population.

Authors:  C Matthew Kinsey; Katharine L Hamlington; Jacqueline O'Toole; Renee Stapleton; Jason H T Bates
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

9.  Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy.

Authors:  Chae Hong Lim; Soo Bin Park; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Yong Chan Ahn; Myung-Ju Ahn; Joon Young Choi
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

10.  Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT.

Authors:  Yi Pan; Carsten Brink; Tine Schytte; Henrik Petersen; Yi-Long Wu; Olfred Hansen
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.